TED133642-2024
Joint Nordic Procurement of Pharmaceuticals - 2025 - NF2.1303.b
- Ordregiver
- Amgros I/S
- Oplyst værdi / estimat
- 11.765.767 EUR
- Frist
- 30.4.2024
- Publiceret
- 5.3.2024
- CPV
- 33600000
- Leveringssted (NUTS)
- 00
Dataposten opdateret . Datakilder, dækning og beregningsmetode.
Beskrivelse
Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.
Procedure og udbudsmateriale
Oplysninger fra bekendtgørelsen kan dække flere delkontrakter. Listerne nedenfor er separate uddrag; rækkefølgen kobler ikke et kriterium til en beskrivelse eller delkontrakt. Kontrollér krav, vægtning, frister, optioner og eventuelle rettelser i originalmaterialet.
Proceduretype (kildens kode)
- open
Beskrivelser af tildelingskriterier
- Price is not the only award criterion and all criteria are stated only in the procurement documents.
Oplyste optioner
- Clause 8.2 of the framework agreement provides for an option for delivery in a pre-agreement period (i.e. before the purchase period begins) and an option for delivery in a post-agreement period (i.e. after the purchase period). The two options may be exercised on the terms and conditions stipulated in the framework agreement. The estimated duration in section 5.1.3 is including the options for renewals. The framework agreements ordinary duration is from 1.4.2025 to 31.3.2027.
Aflevering af tilbud
Andre bekendtgørelser i samme CPV-kategori
Nyeste bekendtgørelser med samme firecifrede CPV-kategori. Listen kan omfatte både åbne udbud og historik.
- Amgros 2026 1.630.b
Amgros I/S
- Rammeaftale om køb af Livmarli (maralixibat)
Amgros I/S
- Amgros 2027 1.1076.a
Amgros I/S
- Rammeaftale om køb af Voranigo (vorasidenib)
Amgros I/S
- Amgros 2026 1.989.a
Amgros I/S
- Amgros 2027 1.1551.a
Amgros I/S